Bavarian Nordic A/S (CPH: BAVA)
Denmark
· Delayed Price · Currency is DKK
192.45
-0.60 (-0.31%)
Nov 21, 2024, 4:59 PM CET
Bavarian Nordic Revenue
Bavarian Nordic had revenue of 1.36B DKK in the quarter ending September 30, 2024, a decrease of -0.95%. This brings the company's revenue in the last twelve months to 6.07B, up 2.78% year-over-year. In the year 2023, Bavarian Nordic had annual revenue of 7.06B with 124.14% growth.
Revenue (ttm)
6.07B
Revenue Growth
+2.78%
P/S Ratio
2.49
Revenue / Employee
3.77M
Employees
1,379
Market Cap
15.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.06B | 3.91B | 124.14% |
Dec 31, 2022 | 3.15B | 1.25B | 66.02% |
Dec 31, 2021 | 1.90B | 45.49M | 2.46% |
Dec 31, 2020 | 1.85B | 1.19B | 179.61% |
Dec 31, 2019 | 662.49M | 161.87M | 32.33% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk A/S | 270.58B |
Coloplast A/S | 27.03B |
Genmab A/S | 19.84B |
Demant A/S | 22.84B |
Zealand Pharma A/S | 76.87M |
H. Lundbeck A/S | 21.44B |
H. Lundbeck A/S | 21.44B |
ALK-Abelló A/S | 5.38B |
Bavarian Nordic News
- 2 days ago - Bullish On Bavarian Nordic's Vaccine Portfolio And Revenue Potential In 2025 - Seeking Alpha
- 4 days ago - Bavarian Nordic's Mpox Moment Fades, But Diversification Shines - Seeking Alpha
- 6 days ago - How one vaccine maker responded to a question about RFK Jr. as health secretary - MarketWatch
- 6 days ago - Bavarian Nordic A/S (BVNKF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Bavarian Nordic A/S 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 6 days ago - Bavarian Nordic reports results for first nine months; reaffirms upgraded guidance for FY24 - Seeking Alpha
- 6 days ago - Bavarian Nordic CEO says Kennedy nomination could fuel vaccine scepticism - Reuters
- 6 days ago - Bavarian Nordic has $340 mln orders for its mpox, smallpox vaccine in 2025 - Reuters